News – Page 125 – Endpoints News

Doses of Lilly's blockbuster GLP-1 in shortage have been pulled from FDA supply list

10 months ago

Massachusetts' plan for $1B in life science investment stalls in state legislature

10 months ago

Iron chelator therapy unexpectedly worsened Alzheimer’s disease in clinical study

10 months ago

Exclusive: Devoted Health raises $112M, plots insurance markets expansion

10 months ago

In Japan, sales of Eisai and Biogen's Alzheimer's drug begin to accelerate

10 months ago

Apogee and Spyre founder launches another autoimmune biotech, and it's got $80M to start

10 months ago

Kyowa Kirin divests China unit, prunes discovery and manufacturing work

10 months ago

23andMe board rejects Anne Wojcicki’s take-private plan, requests changes

10 months ago

PARP biotech backed by more than five pharmas closes after nine years

10 months ago

Galapagos pauses blood cancer CAR-T therapy trial due to one Parkinsonism event

10 months ago

Agios' late-stage Pyrukynd trial in kids with rare blood disorder misses primary endpoint

10 months ago

Former RayzeBio CEO quickly returns with new biotech; Amgen’s global research leader steps down

10 months ago

Exclusive: Ultragenyx secures first funds for Alzheimer's gene therapy spinout

10 months ago

Adaptimmune gets FDA accelerated approval for T cell receptor cell therapy in rare soft tissue cancer

10 months ago

Vertex says about 20 patients have started sickle cell therapy, cuts two rare disease programs

10 months ago

Vir's overhaul brings an end to most virology work — and a beginning with cancer

10 months ago

GSK scores expanded label for Jemperli in first-line endometrial cancer

10 months ago

Despite recent trial success, uniQure plans to cut 65% of staff

10 months ago

RSV market pressure leads to slower launch for Moderna's vaccine

10 months ago

Novartis sues FDA over approval of Entresto generic, following rejection of petition

10 months ago

Pfizer mulls facility sale; GSK penalized in South Korea for administrative breach

10 months ago

Blueprint ups Ayvakit guidance; Aurinia to advance autoimmune disease asset

10 months ago

Arbutus reduces headcount after axing HBV combo trial that features Imfinzi

10 months ago

Sanofi pours €1.3B into new insulin manufacturing plant in Frankfurt

10 months ago

First page Previous page 122 123 124125126 127 128 Next page Last page